190 related articles for article (PubMed ID: 25956553)
21. Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigen.
Gunawardena I; Arendse M; Jameson MB; Plank LD; Gregor RT
ANZ J Surg; 2015 Nov; 85(11):843-8. PubMed ID: 24171785
[TBL] [Abstract][Full Text] [Related]
22. Respiratory survival mechanisms in acetylcholinesterase knockout mouse.
Chatonnet F; Boudinot E; Chatonnet A; Taysse L; Daulon S; Champagnat J; Foutz AS
Eur J Neurosci; 2003 Sep; 18(6):1419-27. PubMed ID: 14511322
[TBL] [Abstract][Full Text] [Related]
23. On functions of cholinesterases during embryonic development.
Paraoanu LE; Steinert G; Klaczinski J; Becker-Röck M; Bytyqi A; Layer PG
J Mol Neurosci; 2006; 30(1-2):201-4. PubMed ID: 17192676
[TBL] [Abstract][Full Text] [Related]
24. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
25. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.
Hartmann J; Kiewert C; Duysen EG; Lockridge O; Greig NH; Klein J
J Neurochem; 2007 Mar; 100(5):1421-9. PubMed ID: 17212694
[TBL] [Abstract][Full Text] [Related]
26. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
Geomela PA; Kontos CK; Yiotakis I; Scorilas A
J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
[TBL] [Abstract][Full Text] [Related]
27. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
[TBL] [Abstract][Full Text] [Related]
28. Induction of CD44 variant 9-expressing cancer stem cells might attenuate the efficacy of chemoradioselection and Worsens the prognosis of patients with advanced head and neck cancer.
Aso T; Matsuo M; Kiyohara H; Taguchi K; Rikimaru F; Shimokawa M; Segawa Y; Higaki Y; Umeno H; Nakashima T; Masuda M
PLoS One; 2015; 10(3):e0116596. PubMed ID: 25751671
[TBL] [Abstract][Full Text] [Related]
29. Activity of cholinesterases in a young and healthy middle-European population: Relevance for toxicology, pharmacology and clinical praxis.
Karasova JZ; Maderycova Z; Tumova M; Jun D; Rehacek V; Kuca K; Misik J
Toxicol Lett; 2017 Aug; 277():24-31. PubMed ID: 28465191
[TBL] [Abstract][Full Text] [Related]
30. Developmental adaptation of central nervous system to extremely high acetylcholine levels.
Farar V; Hrabovska A; Krejci E; Myslivecek J
PLoS One; 2013; 8(7):e68265. PubMed ID: 23861875
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.
de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA
Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240
[TBL] [Abstract][Full Text] [Related]
32. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
[TBL] [Abstract][Full Text] [Related]
33. Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
Lane RM; Potkin SG; Enz A
Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515
[TBL] [Abstract][Full Text] [Related]
34. Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.
Seidensaal K; Nollert A; Feige AH; Muller M; Fleming T; Gunkel N; Zaoui K; Grabe N; Weichert W; Weber KJ; Plinkert P; Simon C; Hess J
Mol Cancer; 2015 Dec; 14():204. PubMed ID: 26634247
[TBL] [Abstract][Full Text] [Related]
35. Cholinesterases are down-expressed in human colorectal carcinoma.
Montenegro MF; Ruiz-Espejo F; Campoy FJ; Muñoz-Delgado E; de la Cadena MP; Rodríguez-Berrocal FJ; Vidal CJ
Cell Mol Life Sci; 2006 Sep; 63(18):2175-82. PubMed ID: 16909200
[TBL] [Abstract][Full Text] [Related]
36. The impact of compliance in posttreatment surveillance in head and neck squamous cell carcinoma.
Deutschmann MW; Sykes KJ; Harbison J; Cabrera-Muffly C; Shnayder Y
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):519-25. PubMed ID: 25950859
[TBL] [Abstract][Full Text] [Related]
37. [Mice lacking individual molecular forms of cholinesterases].
Kučera M; Hrabovská A
Ceska Slov Farm; 2016; 65(2):52-63. PubMed ID: 27356594
[TBL] [Abstract][Full Text] [Related]
38. Remodeling of the neuromuscular junction in mice with deleted exons 5 and 6 of acetylcholinesterase.
Girard E; Bernard V; Camp S; Taylor P; Krejci E; Molgó J
J Mol Neurosci; 2006; 30(1-2):99-100. PubMed ID: 17192646
[TBL] [Abstract][Full Text] [Related]
39. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.
Bongers V; Snow GB; de Vries N; Cattan AR; Hall AG; van der Waal I; Braakhuis BJ
Lab Invest; 1995 Oct; 73(4):503-10. PubMed ID: 7474922
[TBL] [Abstract][Full Text] [Related]
40. Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer.
Takenaka Y; Takemoto N; Yasui T; Yamamoto Y; Uno A; Miyabe H; Ashida N; Shimizu K; Nakahara S; Hanamoto A; Fukusumi T; Michiba T; Cho H; Yamamoto M; Inohara H
PLoS One; 2016; 11(10):e0164057. PubMed ID: 27732629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
